US Medical Tourism Market Size, Share | CAGR Of 20.8%

The US medical tourism market is projected to grow significantly, from USD 6.2 billion in 2024 to USD 41.0 billion by 2034. This growth reflects a strong compound annual growth rate (CAGR) of 20.8% during the forecast period from 2025 to 2034. The rising cost of healthcare globally and the demand for high-quality medical services are major growth drivers. Many international patients are choosing the United States for advanced treatments, including cancer therapy, elective surgeries, fertility treatments, and cosmetic procedures.

Improved healthcare infrastructure and better access to international travel are supporting market expansion. The availability of specialized care and advanced technology in US hospitals enhances its global appeal. Patients often seek treatments unavailable in their home countries, especially complex or experimental procedures. For instance, in September 2023, the Malaysia Healthcare Travel Council formed a partnership with the US-based Mayo Foundation. This collaboration highlights the global trust in US healthcare institutions and their ability to deliver cutting-edge medical expertise.

The market is segmented by service provider into public and private sectors. In 2024, the private segment led the market with a 58.6% share. The preference for private institutions is mainly due to faster service, access to advanced facilities, and customized care. Private hospitals and clinics also focus on patient experience, making them more attractive to international medical travelers. This positions the private sector as a key contributor to the growth of medical tourism in the United States.

By service type, the US medical tourism market is categorized into medical treatment, wellness treatment, and alternative treatment. Among these, medical treatment held the highest share at 52.3% in 2024. This segment includes surgeries, oncology care, organ transplants, and other specialized interventions. The rising adoption of telemedicine and digital consultations further supports market growth by enabling easier access to initial evaluations. The US remains a prime destination for patients seeking a combination of affordability, medical innovation, and personalized care solutions.